This is in line with findings in other pathologies, such as prostate cancer, in which hepsin proteolyzes laminin-332, a cell matrix molecule necessary for cell-to-cell adhesion, thereby enhancing tumor cell invasion (Pant et al., 2018). Here, HPN is linked to prostate cancer.